Literature DB >> 30595504

Comprehensive Analysis of Chromatin States in Atypical Teratoid/Rhabdoid Tumor Identifies Diverging Roles for SWI/SNF and Polycomb in Gene Regulation.

Serap Erkek1, Pascal D Johann2, Martina A Finetti3, Yiannis Drosos4, Hsien-Chao Chou4, Marc Zapatka5, Dominik Sturm2, David T W Jones6, Andrey Korshunov7, Marina Rhyzova8, Stephan Wolf9, Jan-Philipp Mallm10, Katja Beck11, Olaf Witt12, Andreas E Kulozik13, Michael C Frühwald14, Paul A Northcott15, Jan O Korbel16, Peter Lichter17, Roland Eils18, Amar Gajjar4, Charles W M Roberts4, Daniel Williamson3, Martin Hasselblatt19, Lukas Chavez6, Stefan M Pfister2, Marcel Kool20.   

Abstract

Biallelic inactivation of SMARCB1, encoding a member of the SWI/SNF chromatin remodeling complex, is the hallmark genetic aberration of atypical teratoid rhabdoid tumors (ATRT). Here, we report how loss of SMARCB1 affects the epigenome in these tumors. Using chromatin immunoprecipitation sequencing (ChIP-seq) on primary tumors for a series of active and repressive histone marks, we identified the chromatin states differentially represented in ATRTs compared with other brain tumors and non-neoplastic brain. Re-expression of SMARCB1 in ATRT cell lines enabled confirmation of our genome-wide findings for the chromatin states. Additional generation of ChIP-seq data for SWI/SNF and Polycomb group proteins and the transcriptional repressor protein REST determined differential dependencies of SWI/SNF and Polycomb complexes in regulation of diverse gene sets in ATRTs.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  EZH2; SMARCA4; SMARCB1; atypical teratoid rhabdoid tumor; chromatin states; pediatric brain tumor

Mesh:

Substances:

Year:  2018        PMID: 30595504      PMCID: PMC6341227          DOI: 10.1016/j.ccell.2018.11.014

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  50 in total

Review 1.  Chromatin regulation: how complex does it get?

Authors:  Karin Meier; Alexander Brehm
Journal:  Epigenetics       Date:  2014-11       Impact factor: 4.528

2.  Reduced histone H3 K27 trimethylation is encountered in about 50% of atypical teratoid/rhabdoid tumors (AT/RT) but is not associated with molecular subgroup status and outcome.

Authors:  Martin Hasselblatt; Pascal D Johann; Marcel Kool; Michael C Frühwald
Journal:  Acta Neuropathol       Date:  2017-08-16       Impact factor: 17.088

3.  Initial testing (stage 1) of tazemetostat (EPZ-6438), a novel EZH2 inhibitor, by the Pediatric Preclinical Testing Program.

Authors:  Raushan T Kurmasheva; Melissa Sammons; Edward Favours; Jianwrong Wu; Dias Kurmashev; Katherine Cosmopoulos; Heike Keilhack; Christine R Klaus; Peter J Houghton; Malcolm A Smith
Journal:  Pediatr Blood Cancer       Date:  2016-08-24       Impact factor: 3.167

Review 4.  Molecular diagnostics of CNS embryonal tumors.

Authors:  Stefan M Pfister; Andrey Korshunov; Marcel Kool; Martin Hasselblatt; Charles Eberhart; Michael D Taylor
Journal:  Acta Neuropathol       Date:  2010-09-30       Impact factor: 17.088

Review 5.  Exploiting the Epigenome to Control Cancer-Promoting Gene-Expression Programs.

Authors:  Gerard L Brien; Daria G Valerio; Scott A Armstrong
Journal:  Cancer Cell       Date:  2016-04-11       Impact factor: 31.743

6.  SWI/SNF-mutant cancers depend on catalytic and non-catalytic activity of EZH2.

Authors:  Kimberly H Kim; Woojin Kim; Thomas P Howard; Francisca Vazquez; Aviad Tsherniak; Jennifer N Wu; Weishan Wang; Jeffrey R Haswell; Loren D Walensky; William C Hahn; Stuart H Orkin; Charles W M Roberts
Journal:  Nat Med       Date:  2015-11-09       Impact factor: 53.440

7.  Comparison of REST cistromes across human cell types reveals common and context-specific functions.

Authors:  Shira Rockowitz; Wen-Hui Lien; Erika Pedrosa; Gang Wei; Mingyan Lin; Keji Zhao; Herbert M Lachman; Elaine Fuchs; Deyou Zheng
Journal:  PLoS Comput Biol       Date:  2014-06-12       Impact factor: 4.475

8.  HTSeq--a Python framework to work with high-throughput sequencing data.

Authors:  Simon Anders; Paul Theodor Pyl; Wolfgang Huber
Journal:  Bioinformatics       Date:  2014-09-25       Impact factor: 6.937

9.  Integrated (epi)-Genomic Analyses Identify Subgroup-Specific Therapeutic Targets in CNS Rhabdoid Tumors.

Authors:  Jonathon Torchia; Brian Golbourn; Shengrui Feng; King Ching Ho; Patrick Sin-Chan; Alexandre Vasiljevic; Joseph D Norman; Paul Guilhamon; Livia Garzia; Natalia R Agamez; Mei Lu; Tiffany S Chan; Daniel Picard; Pasqualino de Antonellis; Dong-Anh Khuong-Quang; Aline C Planello; Constanze Zeller; Dalia Barsyte-Lovejoy; Lucie Lafay-Cousin; Louis Letourneau; Mathieu Bourgey; Man Yu; Deena M A Gendoo; Misko Dzamba; Mark Barszczyk; Tiago Medina; Alexandra N Riemenschneider; A Sorana Morrissy; Young-Shin Ra; Vijay Ramaswamy; Marc Remke; Christopher P Dunham; Stephen Yip; Ho-Keung Ng; Jian-Qiang Lu; Vivek Mehta; Steffen Albrecht; Jose Pimentel; Jennifer A Chan; Gino R Somers; Claudia C Faria; Lucia Roque; Maryam Fouladi; Lindsey M Hoffman; Andrew S Moore; Yin Wang; Seung Ah Choi; Jordan R Hansford; Daniel Catchpoole; Diane K Birks; Nicholas K Foreman; Doug Strother; Almos Klekner; Laszló Bognár; Miklós Garami; Péter Hauser; Tibor Hortobágyi; Beverly Wilson; Juliette Hukin; Anne-Sophie Carret; Timothy E Van Meter; Eugene I Hwang; Amar Gajjar; Shih-Hwa Chiou; Hideo Nakamura; Helen Toledano; Iris Fried; Daniel Fults; Takafumi Wataya; Chris Fryer; David D Eisenstat; Katrin Scheinemann; Adam J Fleming; Donna L Johnston; Jean Michaud; Shayna Zelcer; Robert Hammond; Samina Afzal; David A Ramsay; Nongnuch Sirachainan; Suradej Hongeng; Noppadol Larbcharoensub; Richard G Grundy; Rishi R Lulla; Jason R Fangusaro; Harriet Druker; Ute Bartels; Ronald Grant; David Malkin; C Jane McGlade; Theodore Nicolaides; Tarik Tihan; Joanna Phillips; Jacek Majewski; Alexandre Montpetit; Guillaume Bourque; Gary D Bader; Alyssa T Reddy; G Yancey Gillespie; Monika Warmuth-Metz; Stefan Rutkowski; Uri Tabori; Mathieu Lupien; Michael Brudno; Ulrich Schüller; Torsten Pietsch; Alexander R Judkins; Cynthia E Hawkins; Eric Bouffet; Seung-Ki Kim; Peter B Dirks; Michael D Taylor; Anat Erdreich-Epstein; Cheryl H Arrowsmith; Daniel D De Carvalho; James T Rutka; Nada Jabado; Annie Huang
Journal:  Cancer Cell       Date:  2016-12-12       Impact factor: 31.743

10.  TSGene: a web resource for tumor suppressor genes.

Authors:  Min Zhao; Jingchun Sun; Zhongming Zhao
Journal:  Nucleic Acids Res       Date:  2012-10-12       Impact factor: 16.971

View more
  25 in total

1.  Targeting MEK/MELK in atypical teratoid rhabdoid tumor: a treatment approach aimed at exploiting blood-brain barrier deficiencies.

Authors:  Dean Popovski; Annie Huang
Journal:  Neuro Oncol       Date:  2020-01-11       Impact factor: 12.300

2.  SWI/SNF complex heterogeneity is related to polyphenotypic differentiation, prognosis, and immune response in rhabdoid tumors.

Authors:  Pooja Panwalkar; Drew Pratt; Chan Chung; Derek Dang; Paul Le; Daniel Martinez; Jill M Bayliss; Kyle S Smith; Mike Adam; Steven Potter; Paul A Northcott; Leo Mascarenhas; Jared Shows; Bruce Pawel; Ashley Margol; Annie Huang; Alexander R Judkins; Sriram Venneti
Journal:  Neuro Oncol       Date:  2020-06-09       Impact factor: 12.300

3.  Advancing biology-based therapeutic approaches for atypical teratoid rhabdoid tumors.

Authors:  Lindsey M Hoffman; Elizabeth Anne Richardson; Ben Ho; Ashley Margol; Alyssa Reddy; Lucie Lafay-Cousin; Susan Chi; Irene Slavc; Alexander Judkins; Martin Hasselblatt; Franck Bourdeaut; Michael C Frühwald; Rajeev Vibhakar; Eric Bouffet; Annie Huang
Journal:  Neuro Oncol       Date:  2020-07-07       Impact factor: 12.300

Review 4.  Molecular targeted therapies for pediatric atypical teratoid/rhabdoid tumors.

Authors:  Chang Zhang; Hao Li
Journal:  Pediatr Investig       Date:  2022-05-23

5.  Locoregionally administered B7-H3-targeted CAR T cells for treatment of atypical teratoid/rhabdoid tumors.

Authors:  Johanna Theruvath; Elena Sotillo; Christopher W Mount; Claus Moritz Graef; Alberto Delaidelli; Sabine Heitzeneder; Louai Labanieh; Shaurya Dhingra; Amaury Leruste; Robbie G Majzner; Peng Xu; Sabine Mueller; Derek W Yecies; Martina A Finetti; Daniel Williamson; Pascal D Johann; Marcel Kool; Stefan Pfister; Martin Hasselblatt; Michael C Frühwald; Olivier Delattre; Didier Surdez; Franck Bourdeaut; Stephanie Puget; Sakina Zaidi; Siddhartha S Mitra; Samuel Cheshier; Poul H Sorensen; Michelle Monje; Crystal L Mackall
Journal:  Nat Med       Date:  2020-04-27       Impact factor: 53.440

6.  Multimodal analysis of cell-free DNA whole-genome sequencing for pediatric cancers with low mutational burden.

Authors:  Peter Peneder; Adrian M Stütz; Didier Surdez; Manuela Krumbholz; Sabine Semper; Mathieu Chicard; Nathan C Sheffield; Gaelle Pierron; Eve Lapouble; Marcus Tötzl; Bekir Ergüner; Daniele Barreca; André F Rendeiro; Abbas Agaimy; Heidrun Boztug; Gernot Engstler; Michael Dworzak; Marie Bernkopf; Sabine Taschner-Mandl; Inge M Ambros; Ola Myklebost; Perrine Marec-Bérard; Susan Ann Burchill; Bernadette Brennan; Sandra J Strauss; Jeremy Whelan; Gudrun Schleiermacher; Christiane Schaefer; Uta Dirksen; Caroline Hutter; Kjetil Boye; Peter F Ambros; Olivier Delattre; Markus Metzler; Christoph Bock; Eleni M Tomazou
Journal:  Nat Commun       Date:  2021-05-28       Impact factor: 14.919

7.  ATRX In-Frame Fusion Neuroblastoma Is Sensitive to EZH2 Inhibition via Modulation of Neuronal Gene Signatures.

Authors:  Zulekha A Qadeer; David Valle-Garcia; Dan Hasson; Zhen Sun; April Cook; Christie Nguyen; Aroa Soriano; Anqi Ma; Lyra M Griffiths; Maged Zeineldin; Dan Filipescu; Luz Jubierre; Asif Chowdhury; Orla Deevy; Xiang Chen; David B Finkelstein; Armita Bahrami; Elizabeth Stewart; Sara Federico; Soledad Gallego; Fumiko Dekio; Mary Fowkes; David Meni; John M Maris; William A Weiss; Stephen S Roberts; Nai-Kong V Cheung; Jian Jin; Miguel F Segura; Michael A Dyer; Emily Bernstein
Journal:  Cancer Cell       Date:  2019-10-17       Impact factor: 38.585

Review 8.  The SWI/SNF complex in cancer - biology, biomarkers and therapy.

Authors:  Priya Mittal; Charles W M Roberts
Journal:  Nat Rev Clin Oncol       Date:  2020-04-17       Impact factor: 66.675

Review 9.  Polycomb repressive complex 2 in the driver's seat of childhood and young adult brain tumours.

Authors:  Brian Krug; Ashot S Harutyunyan; Shriya Deshmukh; Nada Jabado
Journal:  Trends Cell Biol       Date:  2021-06-03       Impact factor: 21.167

Review 10.  Atypical teratoid rhabdoid tumor: molecular insights and translation to novel therapeutics.

Authors:  Cody L Nesvick; Lucie Lafay-Cousin; Aditya Raghunathan; Eric Bouffet; Annie A Huang; David J Daniels
Journal:  J Neurooncol       Date:  2020-10-06       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.